| Skolevideos | Yet | Videocafe | Free TV | Online jokes |
| Free Games | Online Radio | PcPoker | Free online Tv |
Added: Feb 6, 2012
From: webtvcanalinter
Duration: 6:53
SEE MORE ON CANAL INTERNACIONAL: www.ci-webtv.com Nordisk CEO Lars Rebien Sørensen, on 2011 Financial Results Nordisk CEO and president Lars Rebien Sørensen on sales growth in 2011 by 11%, measured in local currencies, Victoza and the competition by Amylins's once-weekly GLP-1 product, Bydureon, launced in Europe and just approved in the US, regulatory update on Degludec, the ultra-long acting insulin from Novo Nordisk now submitted for approval in the US, Europe and Japan, on the Novo Nordisk pipeline, expectations of sales growth in 2012 between 7 and 11 % and finally the fact that Lars Rebien Sørensen has extended his contract as Novo Nordisk CEO until 2019.
Channel: Tech
Tags: business finance market trading news stocks entertainment economy investment obama romney las vegas los angeles san francisco dakota north carolina taiwan pekin london paris leon soccer football tennis health singapore chinese happy new year 2012 medicine italy france veneza grece buenos aires são paulo minas gerais ouro preto
Rating: 5.0' max='5' min='1' numRaters='1' rel='http://schemas.google.com/g/2005#overall ( ratings) Views: 251 Comments: 0
|
|